Mallinckrodt to promote Therakos unit to CVC for $925 million By Investing.com
DUBLIN and LUXEMBOURG - Specialty pharmaceutical firm Mallinckrodt plc (OTC:) has agreed…
Search
Have an existing account?
Sign In
